Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

The pharma giant has received the CDSCO nod to import sodium zirconium cyclosilicate powder for oral suspension (Lokelma) in ...

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...

ITM Isotope Technologies Munich SE is gearing up to enter the US market with its radiopharmaceutical therapy, ITM-11 ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...

After the contentious Senate confirmation of Robert F. Kennedy Jr., another crucial governmental health leadership ...

AstraZeneca Pharma India has received approval to import and sell sodium zirconium cyclosilicate (Lokelma) for treating hyperkalemia in adults in India. The drug is indicated for the treatment of ...

Pharmaceuticals (SCPH) announced that the FDA has approved the supplemental new drug application for Furoscix to expand the indication to ...